| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | fentanyl (Effentora®) |
| Formulation | 100 micrograms, 200 micrograms, 400 micrograms, 600 micrograms and 800 micrograms buccal tablet |
| Reference number | 144 |
| Indication | Treatment of breakthrough pain in adults with cancer who are already receiving maintenance opiod therapy for chronic cancer pain |
| Company | Cephalon Ltd |
| BNF chapter | Central nervous system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 22/07/2008 |